CA Stock MarketDetailed Quotes

PMN ProMIS Neurosciences Inc

Watchlist

6.000
0.0000.00%

15min DelayMarket Closed Apr 11 09:30 ET

51.48MMarket Cap-1644P/E (TTM)

ProMIS Neurosciences Inc Key Stats

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

Assets

Current assets

Cash, cash equivalents and short term investments

-75.62%3.36M

-65.21%5.91M

-81.02%3.95M

59.26%8.94M

97.24%13.79M

1,921.34%16.98M

7,345.86%20.81M

491.41%5.61M

-Cash and cash equivalents

-75.78%3.33M

-65.32%5.88M

-81.13%3.92M

59.64%8.9M

97.70%13.76M

1,999.79%16.94M

8,269.60%20.78M

507.44%5.58M

-Short term investments

-7.62%31.13K

-6.73%31.01K

-7.33%30.54K

-3.58%32.69K

1.21%33.7K

0.86%33.25K

5.47%32.96K

10.70%33.9K

Receivables

-58.81%41.52K

47.11%71.63K

-63.50%60.71K

2.53%56.42K

-46.76%100.81K

56.84%48.69K

269.60%166.34K

87.42%55.03K

-Accounts receivable

----

-46.76%100.81K

----

269.60%166.34K

87.42%55.03K

-Taxes receivable

--41.52K

47.11%71.63K

--60.71K

--56.42K

----

60.76%48.69K

----

Prepaid assets

2.28%533.85K

34.52%920.43K

-52.92%872.53K

78.68%990.36K

233.58%521.92K

570.93%684.24K

1,968.38%1.85M

375.11%554.26K

Current deferred assets

--464.47K

----

--470.05K

--176.9K

----

Other current assets

--5.83K

5.38%4.62K

--4.57K

--1.51K

----

--4.39K

----

Total current assets

-69.42%4.41M

-61.03%6.9M

-76.53%5.36M

63.36%10.16M

96.43%14.42M

1,720.74%17.71M

5,413.54%22.83M

468.18%6.22M

Non current assets

Net PPE

--0

-93.13%321

-98.33%788

-95.25%2.78K

-92.64%5.02K

-94.02%4.67K

-38.99%47.22K

--58.42K

-Gross PPE

----

-4.45%80.32K

--79.1K

--84.67K

----

-48.31%84.06K

----

-Accumulated depreciation

----

-0.77%-80K

---78.32K

---81.89K

----

6.05%-79.39K

----

Investments and advances

----

--0

-Long term equity investment

----

--0

Goodwill and other intangible assets

-26.22%19.67K

-24.54%20.84K

-24.30%21.73K

-20.47%24.56K

-15.78%26.66K

-15.40%27.61K

-11.23%28.71K

-6.20%30.88K

Total non current assets

-37.90%19.67K

-34.46%21.16K

-70.34%22.52K

-69.39%27.33K

-68.36%31.67K

-71.46%32.29K

-32.20%75.93K

171.30%89.3K

Total assets

-69.35%4.43M

-60.98%6.92M

-76.51%5.38M

61.48%10.19M

94.21%14.45M

1,534.09%17.75M

4,254.47%22.91M

459.52%6.31M

Liabilities

Current liabilities

Payables

983.68%6.99M

627.51%2.98M

295.56%1.79M

280.63%888.02K

166.65%644.75K

-6.51%408.98K

-6.98%453.74K

-82.21%233.3K

-accounts payable

983.68%6.99M

627.51%2.98M

295.56%1.79M

280.63%888.02K

166.65%644.75K

-6.51%408.98K

-6.98%453.74K

-82.21%233.3K

Current accrued expenses

130.52%1.72M

560.97%3.44M

386.35%1.3M

359.64%986.03K

560.54%745.51K

1,025.65%520.09K

18.33%268.1K

4.82%214.53K

Current deferred liabilities

----

-25.46%996.82K

--491.3K

Current liabilities

526.18%8.71M

590.26%6.41M

80.30%3.1M

99.55%1.87M

-21.34%1.39M

-50.65%929.07K

-16.23%1.72M

-38.05%939.12K

Non current liabilities

Long term debt and capital lease obligation

----

13.62%4.05M

--3.91M

--3.79M

--3.68M

-Long term debt

----

13.62%4.05M

--3.91M

--3.79M

--3.68M

Derivative product liabilities

-63.89%1.9M

-74.36%1.86M

-84.25%1.55M

-79.88%1.61M

-41.38%5.27M

--7.25M

--9.86M

--7.98M

Non current deferred liabilities

----

--806.5K

Total non current liabilities

-79.59%1.9M

-83.34%1.86M

-88.62%1.55M

-87.13%1.61M

-25.76%9.32M

--11.16M

--13.65M

--12.47M

Total liabilities

-0.94%10.61M

-31.56%8.27M

-69.73%4.65M

-74.05%3.48M

-25.21%10.71M

541.98%12.09M

648.97%15.37M

784.50%13.41M

Shareholders'equity

Share capital

--0

36.03%57.71M

--0

42.22%56.04M

11.84%43.19M

-common stock

--0

36.03%57.71M

--0

42.22%56.04M

11.84%43.19M

-Preferred stock

--0

----

--0

----

Additional paid-in capital

918.19%79.23M

16.26%79.1M

882.40%73.99M

975.20%73.88M

15.54%7.78M

938.96%68.04M

21.00%7.53M

12.64%6.87M

Retained earnings

-23.54%-85.21M

-29.04%-80.25M

-16.22%-72.99M

-5.02%-67.03M

-10.42%-68.97M

-11.31%-62.19M

-19.14%-62.8M

-26.35%-63.83M

Gains losses not affecting retained earnings

---199.72K

-3.96%-195.37K

---270.32K

---138.44K

----

---187.92K

----

Other equity interest

----

12.43%7.22M

----

21.85%6.78M

23.24%6.67M

Total stockholders'equity

-265.25%-6.18M

-123.81%-1.35M

-90.33%729.76K

194.54%6.71M

154.35%3.74M

810.44%5.66M

594.56%7.54M

-1,728.84%-7.1M

Total equity

-265.25%-6.18M

-123.81%-1.35M

-90.33%729.76K

194.54%6.71M

154.35%3.74M

810.44%5.66M

594.56%7.54M

-1,728.84%-7.1M

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021
Assets
Current assets
Cash, cash equivalents and short term investments	-75.62%3.36M	-65.21%5.91M	-65.21%5.91M	-81.02%3.95M	59.26%8.94M	97.24%13.79M	1,921.34%16.98M	1,921.34%16.98M	7,345.86%20.81M	491.41%5.61M
-Cash and cash equivalents	-75.78%3.33M	-65.32%5.88M	-65.32%5.88M	-81.13%3.92M	59.64%8.9M	97.70%13.76M	1,999.79%16.94M	1,999.79%16.94M	8,269.60%20.78M	507.44%5.58M
-Short term investments	-7.62%31.13K	-6.73%31.01K	-6.73%31.01K	-7.33%30.54K	-3.58%32.69K	1.21%33.7K	0.86%33.25K	0.86%33.25K	5.47%32.96K	10.70%33.9K
Receivables	-58.81%41.52K	47.11%71.63K	47.11%71.63K	-63.50%60.71K	2.53%56.42K	-46.76%100.81K	56.84%48.69K	56.84%48.69K	269.60%166.34K	87.42%55.03K
-Accounts receivable	----	----	----	----	----	-46.76%100.81K	----	----	269.60%166.34K	87.42%55.03K
-Taxes receivable	--41.52K	47.11%71.63K	47.11%71.63K	--60.71K	--56.42K	----	60.76%48.69K	60.76%48.69K	----	----
Prepaid assets	2.28%533.85K	34.52%920.43K	34.52%920.43K	-52.92%872.53K	78.68%990.36K	233.58%521.92K	570.93%684.24K	570.93%684.24K	1,968.38%1.85M	375.11%554.26K
Current deferred assets	--464.47K	----	----	--470.05K	--176.9K	----	----	----	----	----
Other current assets	--5.83K	5.38%4.62K	5.38%4.62K	--4.57K	--1.51K	----	--4.39K	--4.39K	----	----
Total current assets	-69.42%4.41M	-61.03%6.9M	-61.03%6.9M	-76.53%5.36M	63.36%10.16M	96.43%14.42M	1,720.74%17.71M	1,720.74%17.71M	5,413.54%22.83M	468.18%6.22M
Non current assets
Net PPE	--0	-93.13%321	-93.13%321	-98.33%788	-95.25%2.78K	-92.64%5.02K	-94.02%4.67K	-94.02%4.67K	-38.99%47.22K	--58.42K
-Gross PPE	----	-4.45%80.32K	-4.45%80.32K	--79.1K	--84.67K	----	-48.31%84.06K	-48.31%84.06K	----	----
-Accumulated depreciation	----	-0.77%-80K	-0.77%-80K	---78.32K	---81.89K	----	6.05%-79.39K	6.05%-79.39K	----	----
Investments and advances	----	----	----	----	----	----	----	----	--0	--0
-Long term equity investment	----	----	----	----	----	----	----	----	--0	--0
Goodwill and other intangible assets	-26.22%19.67K	-24.54%20.84K	-24.54%20.84K	-24.30%21.73K	-20.47%24.56K	-15.78%26.66K	-15.40%27.61K	-15.40%27.61K	-11.23%28.71K	-6.20%30.88K
Total non current assets	-37.90%19.67K	-34.46%21.16K	-34.46%21.16K	-70.34%22.52K	-69.39%27.33K	-68.36%31.67K	-71.46%32.29K	-71.46%32.29K	-32.20%75.93K	171.30%89.3K
Total assets	-69.35%4.43M	-60.98%6.92M	-60.98%6.92M	-76.51%5.38M	61.48%10.19M	94.21%14.45M	1,534.09%17.75M	1,534.09%17.75M	4,254.47%22.91M	459.52%6.31M
Liabilities
Current liabilities
Payables	983.68%6.99M	627.51%2.98M	627.51%2.98M	295.56%1.79M	280.63%888.02K	166.65%644.75K	-6.51%408.98K	-6.51%408.98K	-6.98%453.74K	-82.21%233.3K
-accounts payable	983.68%6.99M	627.51%2.98M	627.51%2.98M	295.56%1.79M	280.63%888.02K	166.65%644.75K	-6.51%408.98K	-6.51%408.98K	-6.98%453.74K	-82.21%233.3K
Current accrued expenses	130.52%1.72M	560.97%3.44M	560.97%3.44M	386.35%1.3M	359.64%986.03K	560.54%745.51K	1,025.65%520.09K	1,025.65%520.09K	18.33%268.1K	4.82%214.53K
Current deferred liabilities	----	----	----	----	----	----	----	----	-25.46%996.82K	--491.3K
Current liabilities	526.18%8.71M	590.26%6.41M	590.26%6.41M	80.30%3.1M	99.55%1.87M	-21.34%1.39M	-50.65%929.07K	-50.65%929.07K	-16.23%1.72M	-38.05%939.12K
Non current liabilities
Long term debt and capital lease obligation	----	----	----	----	----	13.62%4.05M	--3.91M	--3.91M	--3.79M	--3.68M
-Long term debt	----	----	----	----	----	13.62%4.05M	--3.91M	--3.91M	--3.79M	--3.68M
Derivative product liabilities	-63.89%1.9M	-74.36%1.86M	-74.36%1.86M	-84.25%1.55M	-79.88%1.61M	-41.38%5.27M	--7.25M	--7.25M	--9.86M	--7.98M
Non current deferred liabilities	----	----	----	----	----	----	----	----	----	--806.5K
Total non current liabilities	-79.59%1.9M	-83.34%1.86M	-83.34%1.86M	-88.62%1.55M	-87.13%1.61M	-25.76%9.32M	--11.16M	--11.16M	--13.65M	--12.47M
Total liabilities	-0.94%10.61M	-31.56%8.27M	-31.56%8.27M	-69.73%4.65M	-74.05%3.48M	-25.21%10.71M	541.98%12.09M	541.98%12.09M	648.97%15.37M	784.50%13.41M
Shareholders'equity
Share capital	--0	--0	--0	--0	--0	36.03%57.71M	--0	--0	42.22%56.04M	11.84%43.19M
-common stock	--0	--0	--0	--0	--0	36.03%57.71M	--0	--0	42.22%56.04M	11.84%43.19M
-Preferred stock	--0	--0	--0	--0	--0	----	--0	--0	----	----
Additional paid-in capital	918.19%79.23M	16.26%79.1M	16.26%79.1M	882.40%73.99M	975.20%73.88M	15.54%7.78M	938.96%68.04M	938.96%68.04M	21.00%7.53M	12.64%6.87M
Retained earnings	-23.54%-85.21M	-29.04%-80.25M	-29.04%-80.25M	-16.22%-72.99M	-5.02%-67.03M	-10.42%-68.97M	-11.31%-62.19M	-11.31%-62.19M	-19.14%-62.8M	-26.35%-63.83M
Gains losses not affecting retained earnings	---199.72K	-3.96%-195.37K	-3.96%-195.37K	---270.32K	---138.44K	----	---187.92K	---187.92K	----	----
Other equity interest	----	----	----	----	----	12.43%7.22M	----	----	21.85%6.78M	23.24%6.67M
Total stockholders'equity	-265.25%-6.18M	-123.81%-1.35M	-123.81%-1.35M	-90.33%729.76K	194.54%6.71M	154.35%3.74M	810.44%5.66M	810.44%5.66M	594.56%7.54M	-1,728.84%-7.1M
Total equity	-265.25%-6.18M	-123.81%-1.35M	-123.81%-1.35M	-90.33%729.76K	194.54%6.71M	154.35%3.74M	810.44%5.66M	810.44%5.66M	594.56%7.54M	-1,728.84%-7.1M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

PMN ProMIS Neurosciences Inc

ProMIS Neurosciences Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow